1. Home
  2. RAPT vs FCEL Comparison

RAPT vs FCEL Comparison

Compare RAPT & FCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • FCEL
  • Stock Information
  • Founded
  • RAPT 2015
  • FCEL 1969
  • Country
  • RAPT United States
  • FCEL United States
  • Employees
  • RAPT N/A
  • FCEL N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • FCEL Industrial Machinery/Components
  • Sector
  • RAPT Health Care
  • FCEL Energy
  • Exchange
  • RAPT Nasdaq
  • FCEL Nasdaq
  • Market Cap
  • RAPT 122.9M
  • FCEL 130.8M
  • IPO Year
  • RAPT 2019
  • FCEL 1992
  • Fundamental
  • Price
  • RAPT $13.31
  • FCEL $5.62
  • Analyst Decision
  • RAPT Buy
  • FCEL Hold
  • Analyst Count
  • RAPT 5
  • FCEL 6
  • Target Price
  • RAPT $36.75
  • FCEL $14.11
  • AVG Volume (30 Days)
  • RAPT 133.4K
  • FCEL 2.4M
  • Earning Date
  • RAPT 08-07-2025
  • FCEL 09-04-2025
  • Dividend Yield
  • RAPT N/A
  • FCEL N/A
  • EPS Growth
  • RAPT N/A
  • FCEL N/A
  • EPS
  • RAPT N/A
  • FCEL N/A
  • Revenue
  • RAPT N/A
  • FCEL $129,424,000.00
  • Revenue This Year
  • RAPT N/A
  • FCEL $40.32
  • Revenue Next Year
  • RAPT N/A
  • FCEL $36.17
  • P/E Ratio
  • RAPT N/A
  • FCEL N/A
  • Revenue Growth
  • RAPT N/A
  • FCEL 48.62
  • 52 Week Low
  • RAPT $5.67
  • FCEL $3.58
  • 52 Week High
  • RAPT $27.84
  • FCEL $16.65
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 69.39
  • FCEL 51.89
  • Support Level
  • RAPT $10.00
  • FCEL $5.30
  • Resistance Level
  • RAPT $14.09
  • FCEL $6.31
  • Average True Range (ATR)
  • RAPT 1.04
  • FCEL 0.38
  • MACD
  • RAPT 0.42
  • FCEL 0.04
  • Stochastic Oscillator
  • RAPT 87.32
  • FCEL 53.95

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About FCEL FuelCell Energy Inc.

FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company operates in USA, South Korea, Europe and Canada. Majority of revenue is from USA and South Korea.

Share on Social Networks: